Advancing Spectral CT: A First Clinical Experience with Philips Verida

Spectral imaging, faster workflows and lower radiation dose are shaping the next generation of CT diagnostics.

Japan Approves Low-Dose MRI Contrast Agent Ambelvist

Bayer has received the first global approval for its low-dose MRI contrast agent Ambelvist™ (gadoquatrane) in Japan.

Bayer Spotlights Next-Generation MRI and Low-Dose Contrast Agent Gadoquatrane at ECR 2026

At European Congress of Radiology (ECR) 2026, Bayer highlighted new developments in MRI technologies and contrast agents aimed at improving diagnostic efficiency and patient care.

NHS Fife Cuts MRI Scan Times Over 20% With Siemens AI

NHS Fife has implemented Siemens Healthineers’ Deep Resolve technology to shorten MRI scan times by more than 20%. The AI-based image reconstruction approach has reduced waiting times, and enabled nearly 1,900 additional MRI appointments within six months.

AI Tool Accelerates Lung Cancer Detection Across North East London

North East London Cancer Alliance reports faster chest X-ray turnaround times after deploying Qure.ai’s qXR solution through Sectra Amplifier Services, supporting earlier lung cancer detection.

Siemens Healthineers Expands Contrast-Enhanced Mammography and Biopsy Capabilities

Siemens Healthineers has expanded the contrast-enhanced mammography and biopsy capabilities of its MAMMOMAT B.brilliant system with a new image-reconstruction technique designed to support diagnostics in dense breast tissue.